<DOC>
	<DOC>NCT00090519</DOC>
	<brief_summary>The purpose of this study is to determine if ruboxistaurin can help slow the worsening of an eye disease called macular edema in patients with diabetes.</brief_summary>
	<brief_title>Reduction in the Occurrence of Center-Involved Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Ruboxistaurin</mesh_term>
	<criteria>Type 1 or Type 2 diabetes 18 years or older Nonclinically significant diabetic macular edema Mild to moderate diabetic retinopathy in the study eye, vitreous hemorrhage in the study eye Relatively good vision (20/30 or better) Surgery or laser treatment in the study eye Glaucoma in the study eye Glycosylated hemoglobin (HbA1c) greater than 11%, or systolic blood pressure greater than 170 millimeters of mercury (mmHg) Liver disease, dialysis or renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>